Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limb-Girdle Muscular Dystrophy, Type 2D”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Early research (Phase 1)Study completedNCT00494195
What this trial is testing

Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)

Who this might be right for
Muscular Dystrophies
Nationwide Children's Hospital 6
Early research (Phase 1)Ended earlyNCT06747273
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States

Who this might be right for
Limb Girdle Muscular DystrophyLimb Girdle Muscular Dystrophy Type 2D/R3
Sarepta Therapeutics, Inc. 4
Not applicableLooking for participantsNCT05989620
What this trial is testing

Long-Term Development of Muscular Dystrophy Outcome Assessments

Who this might be right for
LGMD1BLGMD1CLGMD1D+26 more
Virginia Commonwealth University 1,000
Testing effectiveness (Phase 2)Study completedNCT01976091
What this trial is testing

A Gene Transfer Therapy Study to Evaluate the Safety of SRP-9004 (Patidistrogene Bexoparvovec) in Participants With Limb-Girdle Muscular Dystrophy, Type 2D (LGMD2D)

Who this might be right for
Limb-Girdle Muscular Dystrophy, Type 2D
Sarepta Therapeutics, Inc. 6
Not applicableActive Not RecruitingNCT04475926
What this trial is testing

The Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Who this might be right for
Limb-girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 205
Not applicableLooking for participantsNCT05902351
What this trial is testing

Natural History Study for Charcot Marie Tooth Disease

Who this might be right for
Charcot-Marie-Tooth DiseaseCharcot-Marie-ToothCharcot-Marie-Tooth Disease, Type IA+45 more
Hereditary Neuropathy Foundation 10,000